Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators

NCT02197845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 353

Last updated 2023-06-02

No results posted yet for this study

Summary

Multi-phase, patient navigator-based program in the Richmond and Tidewater regions of Virginia to demonstrate:

1. the feasibility of using patient navigators to improve the percentage of children and adult (age 15 and older) patients with sickle cell disease (SCD) in SCD specialty care
2. the efficacy of using patient navigators to improve hydroxyurea (HU) (re-)initiation and adherence among adult patients with SCD eligible for HU

(Patient navigators may also be known as public health workers.)

Conditions

Interventions

BEHAVIORAL

Patient Navigator

A specially trained (SCD knowledgable) Patient Navigator will act as a liaison who assists participants in increasing adherence to HU through disease education, addressing barriers to care and improving adherence to HU. PN utilize various techniques geared toward the individual patients needs. Interventions utilized by a PN include improving disease management skills, educational materials about disease, HU adherence, motivational interviewing, care coordination and social support.

BEHAVIORAL

Recruitment into Specialty Care

A specially trained (SCD knowledgeable) Patient Navigator will act as a liaison to participants in increasing adherence to Hydroxyurea. Interventions utilized by a PN include teaching disease management skills, addressing barriers to care, disease education, HU management, motivational interviewing, care coordination and social support.

Sponsors & Collaborators

  • Eastern Virginia Medical School

    collaborator OTHER
  • Children's Hospital of The King's Daughters

    collaborator OTHER
  • Virginia Department of Health

    collaborator OTHER_GOV
  • James Madison University

    collaborator OTHER
  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Wally R Smith, MD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2018-07-07
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02197845 on ClinicalTrials.gov